Ex-FDA scientist criticizes White House's booster announcement as premature and 'not helpful'

The FDA's independent panel of vaccine advisers will meet Friday to consider the ongoing booster shot discussion, as well vote on whether to advise approving boosters for people 16 and older, The New York Times reports. Recently, scientists, administration officials, and public health agencies have been at odds over who needs booster shots and when, despite a White House roll out beginning Sept. 20. The CDC will discuss the matter next week.

Ahead of the meetings, however, former FDA Chief Scientist Dr. Jesse Goodman shared his thoughts on the matter with CNN's New Day, noting that while he believes Biden's chief medical adviser Dr. Anthony Fauci — who has backed the fall booster rollout, given fears of waning vaccine immunity — to have "tremendous expertise," the White House's premature decision was "not helpful."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Brigid Kennedy

Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.